Exact Mass: 419.0358896
Exact Mass Matches: 419.0358896
Found 23 metabolites which its exact mass value is equals to given mass value 419.0358896,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
S-(2,2-Dichloro-1-hydroxy)ethyl glutathione
C12H19Cl2N3O7S (419.03207240000006)
This compound belongs to the family of Peptides. These are compounds containing an amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another.
Methyl 5-(benzylcarbamoylamino)-3-(2,6-dichlorophenyl)-1,2-oxazole-4-carboxylate
C19H15Cl2N3O4 (419.04395700000003)
4-Methylthio-3-butenyl glucosinolate
C12H21NO9S3 (419.03784160000004)
Rosacyanin B
1-Butyl-3-Methylimidazolium Bis(Trifluoromesulfonyl)imide
0,11-DIMETHOXY-6-METHYL-5,6-DIHYDRO-4H-DIBENZO[DE,G]QUINOLINE
Clopidogrel bisulfate
C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent > C190801 - P2Y12 Inhibitor D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors Clopidogrel hydrogen sulfate is an antiplatelet agent to prevent blood clots. Clopidogrel hydrogen sulfate inhibits CYP2B6 and CYP2C19 with IC50s of 18.2 nM and 524 nM, respectively[1]. Clopidogrel hydrogen sulfate is a potent antithrombotic agent that inhibits ADP-induced platelet aggregation[2]．Clopidogrel hydrogen sulfate also is an orally active P2Y(12) inhibitor[5].
3-({4-[(5-Chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide
C17H14ClN5O4S (419.04549940000004)
3-[2-Bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile
Plavix
D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors
[4-(7-Chloro-4-quinolinyl)-1-piperazinyl]-(3,4-dichlorophenyl)methanone
[4-[[5-(2,4-Dichlorophenyl)-3-isoxazolyl]-oxomethyl]-1-piperazinyl]-(2-furanyl)methanone
C19H15Cl2N3O4 (419.04395700000003)
1-S-[(1Z)-5-(methylsulfinyl)-N-(sulfooxy)pent-4-enimidoyl]-1-thio-beta-D-glucopyranose
C12H21NO9S3 (419.03784160000004)
S-(2,2-Dichloro-1-hydroxy)ethyl glutathione
C12H19Cl2N3O7S (419.03207240000006)
Glucoraphenin
C12H21NO9S3 (419.03784160000004)
A glucosinolic acid that consists of 1-thio-beta-D-glucopyranose attached to a 1-(methylsulfinyl)-5-[(sulfooxy)imino]pent-1-en-5-yl group at the anomeric sulfur.
Kobe2602
C14H9F4N5O4S (419.03113620000005)
Kobe2602 is a Ras-Raf interaction inhibitor. Kobe2602 inhibits the binding of H-Ras·GTP to c-Raf-1 RBD with a Ki of 149 μM. Kobe2602 has antitumor activity[1].
{[5-(methylsulfanyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pent-4-en-1-ylidene]amino}oxysulfonic acid
C12H21NO9S3 (419.03784160000004)
7-(3,4-dihydroxyphenyl)-3,13,14-trihydroxy-10-oxo-6,9,19λ⁴-trioxapentacyclo[13.3.1.0⁵,¹⁸.0⁸,¹⁷.0¹¹,¹⁶]nonadeca-1(19),2,4,7,11,13,15,17-octaen-19-ylium
(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-{[(1z)-5-methanesulfinyl-1-(sulfoimino)pent-4-en-1-yl]sulfanyl}oxane-3,4,5-triol
C12H21NO9S3 (419.03784160000004)
[(z)-[(4e)-5-(methylsulfanyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pent-4-en-1-ylidene]amino]oxysulfonic acid
C12H21NO9S3 (419.03784160000004)